Publications by authors named "Tyler A Cunningham"

Claim this Profile
B
Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell Immunotherapy.
Paola Manara, Austin D Newsam, Venu Venkatarame Gowda Saralamma, Tyler Andrew Cunningham, Drew Lazenby

Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy.
Paola Manara, Austin D Newsam, Venu Vg Saralamma, Marco V Russo, Alicia Bilbao Martinez, Tyler A Cunningham

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MATRIX platform to analyze translation machinery remodeling in glioblastoma cells.
J J David Ho, Tyler A Cunningham, Jonathan R Krieger, Jonathan H Schatz, Stephen Lee

STAR Protoc· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of an eIF4A Inhibitor with a Novel Mechanism of Action.
Christopher J Zerio, Tyler A Cunningham, Allison S Tulino, Erin A Alimusa, Thomas M Buckley

J Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome.
J J David Ho, Tyler A Cunningham, Paola Manara, Caroline A Coughlin, Artavazd Arumov

Cell Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Dynamics Simulations Identify Tractable Lead-like Phenyl-Piperazine Scaffolds as eIF4A1 ATP-competitive Inhibitors.
Derek J Essegian, Tyler A Cunningham, Christopher J Zerio, Eli Chapman, Jonathan Schatz

ACS Omega· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
eIF4A inhibition: ready for primetime?
Tyler A Cunningham, Eli Chapman, Jonathan H Schatz

Oncotarget· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
Eva M Garrido-Martin, Ha-Long Nguyen, Tyler A Cunningham, Se-Woon Choe, Zhihua Jiang

Arterioscler Thromb Vasc Biol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis